inflammatory bowel disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with ulcerative colitis or Crohn's disease Patients whom we get informed consent
Exclusion criteria
Exclusion criteria: Patients with Inflammatory bowel disease, unclassified patients Patients who refused to participate in this study Patients judged to be ineligible by the research director
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety felt by patients with inflammatory bowel disease due to the COVID-19 pandemic | — |
Secondary
| Measure | Time frame |
|---|---|
| Whether there is a change in the consultation behavior or medication of patients with inflammatory bowel disease due to COVID-19 pandemic Relationship between anxiety felt by patients with inflammatory bowel disease due to the COVID-19 pandemic and their background and residence Relationship between consultation behavior and drug changes in patients with inflammatory bowel disease due to the COVID-19 pandemic and their background and residence | — |
Countries
Japan
Contacts
Sapporo Medical University School of Medicine Department of Gastroenterology and Hepatology